Japan Tissue Engineering Co (TSE:7774) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co ROE % Adjusted to Book Value?

Japan Tissue Engineering Co's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Japan Tissue Engineering Co's PB Ratio for the quarter that ended in Sep. 2024 was 3.55. Japan Tissue Engineering Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 0.00%.

Japan Tissue Engineering Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Japan Tissue Engineering Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co ROE % Adjusted to Book Value Chart

Japan Tissue Engineering Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-1.20

-1.47

-2.30

-3.25

0.53

Japan Tissue Engineering Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															0.23	-0.45	-0.81	2.94	-

Competitive Comparison of Japan Tissue Engineering Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Japan Tissue Engineering Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Japan Tissue Engineering Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Japan Tissue Engineering Co ROE % Adjusted to Book Value Calculation

Japan Tissue Engineering Co's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.38%	/	4.47
	=	0.53%

Japan Tissue Engineering Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	3.55
	=	0.00%

Japan Tissue Engineering Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Japan Tissue Engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022

Website

https://www.jpte.co.jp

Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines